BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
+21.75%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$867M
AUM Growth
+$867M
(+20%)
Cap. Flow
+$2.65M
Cap. Flow
% of AUM
0.31%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
|
$2.65M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 51.27% |
| 2 | Consumer Staples | 34.29% |
| 3 | Industrials | 6.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
STAAR Surgical
STAA
$1.36B
| $381M | 43.96% | 10,840,630 | – | – |
|
2
Monster Beverage
MNST
$60.9B
| $297M | 34.29% | 4,679,308 | – | – |
|
3
iShares Russell 2000 ETF
IWM
$67B
| $69.6M | 8.02% | 420,000 | – | – |
|
4
Axon Enterprise
AXON
$58.7B
| $55.7M | 6.42% | 760,062 | – | – |
|
5
Lineage Cell Therapeutics
LCTX
$267M
| $30.3M | 3.49% | 34,005,379 | – | – |
|
|
IMDX
6
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $27.6M | 3.18% | 12,274,738 +1,176,471 | +11% | +$2.65M |
|
7
Serina Therapeutics
SER
$54.5M
| $5.46M | 0.63% | 2,997,156 | – | – |
|